Literature DB >> 29224674

Drivers of the immunopathogenesis in systemic lupus erythematosus.

Thomas Rose1, Thomas Dörner2.   

Abstract

This review summarises a number of current insights into the pathogenesis of SLE. On the basis of the interaction of environmental factors within a predisposed host, a chronic autoimmune process gains function with a positive feed-forward loop between innate and adaptive immunity. A current focus of SLE pathogenesis is on the enhanced production of certain cytokines, such as type I interferons and BLyS/BAFF, suggesting continuous plasmacytoid dendritic and myeloid cell activity together with disturbances of B lineage cells (increased autoantibodies, including anti-dsDNA and plasmablasts, which correlate with SLE activity and memory B-cell abnormalities). Recent studies provided evidence that CD4+ and CD8+ T cells and B cells are hyporesponsive in SLE, likely reflecting their 'post-activation status'. Data of enhanced protein tyrosine phosphatase activity of lymphocytes in SLE require consideration if they represent a disease characteristic. Better understanding of the chronic autoimmune phase is needed in addition to those phases during flares and will permit improved treatment of SLE.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  B cells; Etiopathogenesis; IL-2 deficiency; Inflammation; Interferon; SLE; TLR

Mesh:

Substances:

Year:  2017        PMID: 29224674     DOI: 10.1016/j.berh.2017.09.007

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  14 in total

Review 1.  [Biologicals and small molecules for systemic lupus erythematosus].

Authors:  M Aringer; N Leuchten; T Dörner
Journal:  Z Rheumatol       Date:  2020-04       Impact factor: 1.372

2.  Role of the Specialized Proresolving Mediator Resolvin D1 in Systemic Lupus Erythematosus: Preliminary Results.

Authors:  Luca Navarini; Tiziana Bisogno; Domenico Paolo Emanuele Margiotta; Alessandra Piccoli; Silvia Angeletti; Alice Laudisio; Massimo Ciccozzi; Antonella Afeltra; Mauro Maccarrone
Journal:  J Immunol Res       Date:  2018-10-21       Impact factor: 4.818

Review 3.  MicroRNA Post-transcriptional Regulation of the NLRP3 Inflammasome in Immunopathologies.

Authors:  Gulcin Tezcan; Ekaterina V Martynova; Zarema E Gilazieva; Alan McIntyre; Albert A Rizvanov; Svetlana F Khaiboullina
Journal:  Front Pharmacol       Date:  2019-05-01       Impact factor: 5.810

Review 4.  Therapeutic Potential of ω-3 Polyunsaturated Fatty Acids in Human Autoimmune Diseases.

Authors:  Xiaoxi Li; Xinyun Bi; Shuai Wang; Zongmeng Zhang; Fanghong Li; Allan Z Zhao
Journal:  Front Immunol       Date:  2019-09-27       Impact factor: 7.561

Review 5.  Molecular and Cellular Bases of Immunosenescence, Inflammation, and Cardiovascular Complications Mimicking "Inflammaging" in Patients with Systemic Lupus Erythematosus.

Authors:  Chang-Youh Tsai; Chieh-Yu Shen; Hsien-Tzung Liao; Ko-Jen Li; Hui-Ting Lee; Cheng-Shiun Lu; Cheng-Han Wu; Yu-Min Kuo; Song-Chou Hsieh; Chia-Li Yu
Journal:  Int J Mol Sci       Date:  2019-08-09       Impact factor: 5.923

6.  The regulation and pharmacological modulation of immune complex induced type III IFN production by plasmacytoid dendritic cells.

Authors:  Karin Hjorton; Niklas Hagberg; Pascal Pucholt; Maija-Leena Eloranta; Lars Rönnblom
Journal:  Arthritis Res Ther       Date:  2020-06-05       Impact factor: 5.156

Review 7.  Aberrant Non-Coding RNA Expression in Patients with Systemic Lupus Erythematosus: Consequences for Immune Dysfunctions and Tissue Damage.

Authors:  Chang-Youh Tsai; Chieh-Yu Shen; Chih-Wei Liu; Song-Chou Hsieh; Hsien-Tzung Liao; Ko-Jen Li; Cheng-Shiun Lu; Hui-Ting Lee; Cheng-Sung Lin; Cheng-Han Wu; Yu-Min Kuo; Chia-Li Yu
Journal:  Biomolecules       Date:  2020-12-06

Review 8.  Targeting B Cells and Plasma Cells in Autoimmune Diseases.

Authors:  Katharina Hofmann; Ann-Katrin Clauder; Rudolf Armin Manz
Journal:  Front Immunol       Date:  2018-04-23       Impact factor: 7.561

Review 9.  Systemic Lupus Erythematosus: An Overview of the Disease Pathology and Its Management.

Authors:  Asad Ali; Zohaib Sayyed; Muhammad Atif Ameer; Abdul Wahab Arif; Fnu Kiran; Ayesha Iftikhar; Waleed Iftikhar; Malik Qistas Ahmad; Muhammad Bilal Malik; Vijay Kumar; Arjan Dass; Shahzad Ahmed Sami; Fnu Sapna; Neha Waqas
Journal:  Cureus       Date:  2018-09-11

10.  Deep Phenotyping of Urinary Leukocytes by Mass Cytometry Reveals a Leukocyte Signature for Early and Non-Invasive Prediction of Response to Treatment in Active Lupus Nephritis.

Authors:  Martina Bertolo; Sabine Baumgart; Pawel Durek; Anette Peddinghaus; Henrik Mei; Thomas Rose; Philipp Enghard; Andreas Grützkau
Journal:  Front Immunol       Date:  2020-03-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.